过去一年中添加的文章，按日期排序
[引用][C] The month in heart failure! September 2024
A Abdin, A Aimo, J Hoevelmann, B Haring - 2024 - Wiley Online Library
18 天前 - … Additionally, a study evaluated the effect of dapagliflozin according to QRS duration
across the spectrum of left ventricular ejection fraction (LVEF).Finally, novel data explored …
across the spectrum of left ventricular ejection fraction (LVEF).Finally, novel data explored …
Comprehensive evaluation of patient with heart failure due to ischemic heart disease
30 天前 - … Ischemic heart disease can lead to heart failure. This clinical case study aims to
provide … After discharge, he was advised to continue treatment with dapagliflozin, angiotensin II …
provide … After discharge, he was advised to continue treatment with dapagliflozin, angiotensin II …
Author's reply to the letter to the editor:“Effects of dapagliflozin and empagliflozin on 6‑min walk distance in heart failure with preserved and reduced ejection fraction: A …
M Tanashat, A Manasrah, M Abouzid - European Journal of Clinical …, 2024 - Springer
66 天前 - … that this study had some concerns but not a high risk of bias; hence, it was not
excluded. While in some cases, with numerous studies … , this approach did not apply to our study. …
excluded. While in some cases, with numerous studies … , this approach did not apply to our study. …
[HTML][HTML] Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Are Beta-Blockers Still Relevant?
J Hyun - International Journal of Heart Failure, 2024 - ncbi.nlm.nih.gov
67 天前 - … study is the highlight of the differential effects of BBs based on HR in patients with
AF. A prior study … and AF, 17) and the current study may suggest a potential mechanism and …
AF. A prior study … and AF, 17) and the current study may suggest a potential mechanism and …
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?
P Karakasis, N Fragakis, K Kouskouras… - Clinical Therapeutics, 2024 - Elsevier
79 天前 - … -MI (Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure) trial did
not … very recent retrospective study involving 100 patients (53 treated with dapagliflozin; 47 …
not … very recent retrospective study involving 100 patients (53 treated with dapagliflozin; 47 …
[HTML][HTML] The Societal Burden of Heart Failure With Preserved or Mid-Range Ejection Fraction
WS Weintraub, M Alva - JACC: Advances, 2024 - jacc.org
88 天前 - … -valsartan to valsartan, and dapagliflozin to placebo. The … with stable, symptomatic
heart failure and ejection fraction … of this study, which would be noted in most studies of …
heart failure and ejection fraction … of this study, which would be noted in most studies of …
POS0939 SERUM URATE CHANGE AMONG GOUT PATIENTS TREATED WITH SODIUM-GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS VS …
C Yokose, G Challener, B Jiang, B Zhou, N Mccormick… - 2024 - ard.bmj.com
118 天前 - … 2 diabetes, heart failure, and chronic kidney disease (CKD… comparative effectiveness
cohort study of patients with … of SGLT2i or sulfonylurea during the study period (up to 6 …
cohort study of patients with … of SGLT2i or sulfonylurea during the study period (up to 6 …
Effect of SGLT2 and dual SGLT1/2 Inhibition on the Development of Salt-induced Hypertension
V Levchenko, O Kravtsova, G Upadhyay… - …, 2024 - journals.physiology.org
129 天前 - … for the treatment of heart failure independent of ejection fraction… The main goal of
this study was to define the effects of … In our recent studies, we showed that SGLTi dapagliflozin …
this study was to define the effects of … In our recent studies, we showed that SGLTi dapagliflozin …
Inhibition of SGL2 Prevents Albumin Induced Proximal Tubule Inflammation
R Almutlaq, A Veiga, A Dayton, S Guntipally… - …, 2024 - journals.physiology.org
129 天前 - … Albuminuria is an independent risk factor for cardiovascular disease and … provide
additional benefits beyond their glucose control, including decreased albuminuria. In this study…
additional benefits beyond their glucose control, including decreased albuminuria. In this study…
Biotechnological methods for the study of cardiomyopathies and the evaluation of new pharmacological therapies based on patient-specific in vitro models
L Giammarino - 2024 - tesidottorato.depositolegale.it
134 天前 - … For these reasons, we performed acute treatment with Dapagliflozin (1 and 5 µM) on
DMD-… of heart disease is significantly increase, but the development of models to study the …
DMD-… of heart disease is significantly increase, but the development of models to study the …